Virtu Financial LLC Synlogic, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.56 - $1.07 $501 - $957	895 Added 4.94%	19,005 $12,000
Q4 2022 Feb 15, 2023	BUY	$0.58 - $17.99 $10,503 - $325,798	18,110 New	18,110 $14,000
Q4 2021 Feb 17, 2022	SELL	$2.27 - $3.0 $62,558 - $82,677	-27,559 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.45 - $4.1 $70,432 - $117,866	-28,748 Reduced 51.06%	27,559 $84,000
Q2 2021 Sep 17, 2021	BUY	$3.0 - $4.39 $168,921 - $247,187	56,307 New	56,307 $219,000
Q2 2020 Aug 07, 2020	SELL	$1.59 - $2.51 $29,839 - $47,105	-18,767 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.96 - $2.81 $36,783 - $52,735	18,767 New	18,767 $48,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.